Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study

被引:47
|
作者
Leino, Kari [1 ]
Hynynen, Markku [2 ]
Jalonen, Jouko [1 ]
Salmenpera, Markku [3 ]
Scheinin, Harry [4 ]
Aantaa, Riku [1 ]
机构
[1] Turku Univ Hosp, Dept Anaesthesiol Intens Care Emergency Care & Pa, FIN-20520 Turku, Finland
[2] Jorvi Hosp, Helsinki Univ Hosp, Dept Anesthesia & Intens Care Med, SF-02740 Espoo, Finland
[3] Helsinki Univ Hosp, Dept Anesthesiol & Intens Care, Helsinki, Finland
[4] Univ Turku, Dept Pharmacol, Turku, Finland
来源
BMC ANESTHESIOLOGY | 2011年 / 11卷
关键词
REPLACEMENT THERAPY; AGONISTS; LONG; DETERIORATION; ISOFLURANE; MORTALITY; RISK;
D O I
10.1186/1471-2253-11-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally-mediated sympatholysis. Coronary artery bypass grafting (CABG) with extracorporeal circulation is a stressful procedure increasing sympathetic nervous system activity which could attenuate renal function due the interrelation of sympathetic nervous system, hemodynamics and renal function. We tested the hypothesis that dexmetomidine would improve kidney function in patients undergoing elective CABG during the first two postoperative days. Methods: This was a double-blind, randomized, parallel-group study. Patients with normal renal function and scheduled for elective CABG were randomized to placebo or to infusion of dexmedetomidine to achieve a pseudo steady-state plasma concentration of 0.60 ng/ml. The infusion was started after anesthesia induction and continued until 4 h after surgery. The primary endpoint was creatinine clearance. Other variables included urinary creatinine and output, fractional sodium and potassium excretion, urinary potassium, sodium and glucose, serum and urinary osmolality and plasma catecholamine concentrations. The data were analyzed with repeated-measures ANOVA or Cochran-Mantel-Haenszel test. Results: Sixty-six of 87 randomized patients were evaluable for analysis. No significant between-group differences were recorded for any indices of renal function except for a mean 74% increase in urinary output with dexmedetomidine in the first 4 h after insertion of a urinary catheter (p < 0.001). Confidence interval examination revealed that the sample size was large enough for the no-difference statement for creatinine clearance. Conclusions: Use of intravenous dexmedetomidine did not alter renal function in this cohort of relatively low-risk elective CABG patients but was associated with an increase in urinary output. This study was carried out in 1994-1997 and was thus not registered.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] RANDOMIZED WITHDRAWAL FROM NIFEDIPINE - PLACEBO-CONTROLLED STUDY IN PATIENTS WITH CORONARY-ARTERY SPASM
    SCHICK, EC
    LIANG, CS
    HEUPLER, FA
    KAHL, FR
    KENT, KM
    KERIN, NZ
    NOBLE, RJ
    RUBENFIRE, M
    TABATZNIK, B
    TERRY, RW
    AMERICAN HEART JOURNAL, 1982, 104 (03) : 690 - 697
  • [32] RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE EFFECT OF VERAPAMIL ON EXERCISE HEMODYNAMICS IN CORONARY-ARTERY DISEASE
    PATTON, JN
    VLIETSTRA, RE
    FRYE, RL
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (06): : 674 - 678
  • [33] RANDOMIZED, PLACEBO-CONTROLLED STUDY OF VERAPAMIL ON EXERCISE HEMODYNAMICS IN PATIENTS WITH CORONARY-ARTERY DISEASE
    PATTON, JN
    VLIETSTRA, RE
    FRYE, RL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 265 - 265
  • [34] The Efficacy and Safety of Dexmedetomidine for Sedation During Surgery Under Epidural or Spinal Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Study
    Inagaki, Yoshimi
    Yamakage, Michiaki
    Sakamoto, Atsuhiro
    Okayama, Akifumi
    Oya, Nobuyo
    Hiraoka, Takehiko
    Morita, Kiyoshi
    YONAGO ACTA MEDICA, 2022, 65 (01) : 14 - 25
  • [35] Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients:: A randomized, double-blind, placebo-controlled study
    Gomes, JA
    Ip, J
    Santoni-Rugiu, F
    Mehta, D
    Ergin, A
    Lansman, S
    Pe, E
    Newhouse, TT
    Chao, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (02) : 334 - 339
  • [36] The effect of spironolactone in reducing the risk of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: randomized single-blind placebo-controlled study
    Farzaneh, Ava
    Moradi, Mehdi
    Safarpoor, Gholamreza
    Karamian, Armin
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2024,
  • [37] IMMEDIATE POSTOPERATIVE ASPIRIN IMPROVES VEIN GRAFT PATENCY EARLY AND LATE AFTER CORONARY-ARTERY BYPASS GRAFT-SURGERY - A PLACEBO-CONTROLLED, RANDOMIZED STUDY
    GAVAGHAN, TP
    GEBSKI, V
    BARON, DW
    CIRCULATION, 1991, 83 (05) : 1526 - 1533
  • [38] Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial
    Husedzinovic, I
    Barisin, S
    Bradic, N
    Barisin, A
    Sonicki, Z
    Milanovic, R
    CROATIAN MEDICAL JOURNAL, 2005, 46 (06) : 950 - 956
  • [39] Propofol and Midazolam versus propofol alone for sedation following coronary artery bypass grafting: A randomized, placebo-controlled trial
    Walder, B
    Borgeat, A
    Suter, PM
    Romand, JA
    ANAESTHESIA AND INTENSIVE CARE, 2002, 30 (02) : 171 - 178
  • [40] A Prospective, Randomized, Placebo-Controlled Study of Inferior Turbinate Surgery
    Harju, Teemu
    Numminen, Jura
    Kivekas, Ilkka
    Rautiainen, Markus
    LARYNGOSCOPE, 2018, 128 (09): : 1997 - 2003